Cytomed Therapeutics reported earnings per share of S$0.09 in the first half, compared to a loss of S$0.22 in the same period last year.

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly’s real-time, streaming news feed keeps individual…

Read More: https://thefly.com/permalinks/entry.php/id3990255/GDTC-Cytomed-Therapeutics-H-EPS-S-vs-S-last-year1727695552